OHSU and Regence BlueCross BlueShield of Oregon reach a new agreement that will keep OHSU in network for Regence commercial members. In an OHSU News story, Shereef Elnahal, M.D., says, “OHSU believes that all Oregonians should have access to the best care possible."

BridgeBio Pharma, Inc., announces the first participant in a clinical trial testing a small molecule on transthyretin amyloid cardiomyopathy, or TTR. Ahmad Masri, M.D., says, “It may allow the heart to recover function and remodel favorably over time.”

A news release from Portland State University highlights a new grant award from the National Science Foundation to accelerate the development of commercially viable biotechnology, noting that one of the three initial seed projects is a non-invasive, wearable glucose sensor validated with OHSU and an industry partner.

Electronic Dance Music covers a recent study by Laurence Trussell, Ph.D., and collaborators that revealed the same neurotransmitter commonly used to relieve symptoms of depression and anxiety also may exacerbate tinnitus.

The Eugene Weekly reports on a Eugene practitioner who teaches a migraine and headache prevention class, noting he had previously collaborated with Philip Copenhaver, Ph.D., and Shirley McCartney, Ph.D., of OHSU.

Cardiovascular Business reports that the Society of Cardiovascular Angiography and Interventions is raising concern about interventional cardiologists being told to use procedural volume reporting requirements to maintain their certification. Joaquin Cigarroa, M.D., the organization’s president-elect, says, “There is in fact no direct assessment of clinical outcomes, and therefore this provides a narrow, incomplete view of the work that we do, and of the quality of our clinical work.”

KPTV-TV interviews Alison Chiang, M.D., about keeping kids healthy as they return to school. She says, “My big thing is to recommend that everybody going back to school is getting up to date on their vaccines.”

OHSU and Regence BlueCross BlueShield of Oregon reach a new agreement that will keep OHSU in network for Regence commercial members. In an OHSU News story, Shereef Elnahal, M.D., says, “OHSU believes that all Oregonians should have access to the best care possible."

OHSU and Regence BlueCross BlueShield of Oregon reach a new agreement that will keep OHSU in network for Regence commercial members. In an OHSU News story, Shereef Elnahal, M.D., says, “OHSU believes that all Oregonians should have access to the best care possible.”

A University of North Carolina news release announces researchers at UNC and OHSU have received a $4 million, six-year award from the National Cancer Institute of the National Institutes of Health to improve cancer screenings at community clinics across Oregon and North Carolina. The initiative will be co-led by Melinda Davis, Ph.D., from OHSU.